Concentra Group Holdings Parent, Inc. CON
Set alert
At close · Oct 30
After hours · Oct 30, 4:30 PM ET
- YTD
- +105.18%
- 1 year
- +101.10%
- Open
- 41.45
- Prev close
- 41.25
- Mkt cap
- 5.15B
- Vol
- 989.86K
- Avg vol
- 1.04M
- EPS
- 1.55
- P/E
- 26.05
- Div yield
- 0.61%
More statistics
- Low
- 40.32
- High
- 41.52
- Forward P/E
- 21.90
- Beta
- 0.63
- Short ratio
- 3.00
- Inst. own
- 91.06%
- Dividend
- 0.25
- Ex-div date
- Aug 19, 2026
- Earnings
- Nov 5, 2026
- 50-d avg
- 36.21
- 200-d avg
- 28.40
- 1y target
- 42.00
1Y chart
Events in this range
- Nov 6, 2025Earnings: 0.39; estimate 0.37; surprise 5.41%
- Dec 2, 2025Dividend: 0.0625
- Jan 28, 2026Earnings: 0.28; estimate 0.2268; surprise 23.46%
- Mar 12, 2026Dividend: 0.0625
- May 7, 2026Earnings: 0.4; estimate 0.35; surprise 14.29%
- May 19, 2026Dividend: 0.0625
- Aug 6, 2026Earnings: 0.52; estimate 0.4216; surprise 23.34%
- Aug 10, 2026Rating: RBC Capital · Outperform → Outperform
- Aug 10, 2026Rating: Truist Securities · Buy → Buy
- Aug 11, 2026Rating: Wells Fargo · Overweight → Overweight
- Aug 20, 2026Dividend: 0.0625
- Sep 10, 2026Rating: JP Morgan · Overweight → Overweight
- Oct 16, 2026Rating: Jefferies · — → Buy
- Oct 20, 2026Rating: Stephens & Co. · — → Overweight
Signals (53)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 28, 2026 | 4 days ago |
| RSI: Overbought | Oct 26, 2026 | 6 days ago |
| RSI: Overbought | Oct 21, 2026 | 1 week ago |
| RSI: Overbought | Oct 15, 2026 | 2 weeks ago |
| RSI: Overbought | Oct 12, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 10, 2026 | 2 months ago |
| RSI: Overbought | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 11, 2026 | 4 months ago |
| RSI: Overbought | Jun 11, 2026 | 4 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| RSI: Overbought | May 8, 2026 | 5 months ago |
| SMA: Bullish | May 1, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 22, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| SMA: Bullish | Apr 17, 2026 | 6 months ago |
| SMA: Bearish | Apr 15, 2026 | 6 months ago |
| SMA: Bullish | Apr 14, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 9, 2026 | 6 months ago |
| SMA: Bullish | Apr 7, 2026 | 6 months ago |
| SMA: Bearish | Apr 2, 2026 | 7 months ago |
| SMA: Bullish | Mar 31, 2026 | 7 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| SMA: Bearish | Mar 19, 2026 | 7 months ago |
| SMA: Bullish | Mar 13, 2026 | 7 months ago |
| SMA: Bearish | Mar 12, 2026 | 7 months ago |
| MACD: Sell Signal | Feb 20, 2026 | 8 months ago |
| RSI: Overbought | Feb 10, 2026 | 8 months ago |
| RSI: Overbought | Feb 4, 2026 | 8 months ago |
| RSI: Overbought | Jan 20, 2026 | 9 months ago |
| SMA: Bullish | Jan 15, 2026 | 9 months ago |
| SMA: Bullish | Jan 8, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 8, 2026 | 9 months ago |
| SMA: Bearish | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 7, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 6, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 5, 2026 | 9 months ago |
| SMA: Bearish | Dec 31, 2025 | 10 months ago |
| SMA: Bullish | Dec 26, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 23, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 5, 2025 | 11 months ago |
| SMA: Bearish | Dec 3, 2025 | 11 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 12, 2025 | 11 months ago |
| RSI: Oversold | Nov 5, 2025 | 12 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
Key statistics
- Market cap
- 5.15B
- Enterprise value
- 7.28B
- Trailing P/E
- 26.06
- Forward P/E
- 21.90
- PEG ratio
- 0.00
- Price / sales
- 2.25
- Price / book
- 10.80
- EPS (TTM)
- 1.55
- Beta
- 0.63
- Dividend yield
- 0.61%
- Payout ratio
- 16.13%
- Profit margin
- 8.69%
- Revenue (TTM)
- 2.29B
- Revenue growth
- 10.00%
- Free cash flow
- 204.79M
- Total cash
- 158.04M
- Total debt
- 2.14B
- Return on equity
- 47.06%
- Shares outstanding
- 127.52M
- Short % of float
- 5.08%
- 50-day average
- 36.21
- 200-day average
- 28.40
Analyst view
Consensus: strong buy
- Target (low)
- 40.00
- Target (mean)
- 42.00
- Target (high)
- 47.00
- Strong buy2
- Buy9
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.43914.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 0.4396 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.4216 | 0.52 | +0.10 | +23.34% |
| May 7, 2026 | Mar 31, 2026 | 0.35 | 0.40 | +0.05 | +14.29% |
| Jan 28, 2026 | Dec 31, 2025 | 0.2268 | 0.28 | +0.05 | +23.46% |
| Nov 6, 2025 | Sep 30, 2025 | 0.37 | 0.39 | +0.02 | +5.41% |
| Aug 7, 2025 | Jun 30, 2025 | 0.37 | 0.37 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | Stephens & Co. | init | — | Overweight |
| Oct 16, 2026 | Jefferies | init | — | Buy |
| Sep 10, 2026 | JP Morgan | main | Overweight | Overweight |
| Aug 11, 2026 | Wells Fargo | main | Overweight | Overweight |
| Aug 10, 2026 | Truist Securities | main | Buy | Buy |
| Aug 10, 2026 | RBC Capital | main | Outperform | Outperform |
About Concentra Group Holdings Parent, Inc.
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company operates in three segments: Occupational Health centers, Onsite health clinics, and Other business. It offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- concentra.com
News
- Is Concentra Group Holdings Parent, Inc. (CON) Stock Outpacing Its Medical Peers This Year?
- Stephens & Co. Initiates Coverage On Concentra Group Holdings with Overweight Rating, Announces Price Target of $45
- Jefferies Initiates Coverage On Concentra Group Holdings with Buy Rating, Announces Price Target of $47
- JP Morgan Maintains Overweight on Concentra Group Holdings, Raises Price Target to $43
- Wells Fargo Maintains Overweight on Concentra Group Holdings, Raises Price Target to $40
- Truist Securities Maintains Buy on Concentra Group Holdings, Raises Price Target to $42
- RBC Capital Maintains Outperform on Concentra Group Holdings, Raises Price Target to $42
- CORRECTION: Concentra Group Holdings Q2 Adj. EPS $0.52 Beats $0.42 Estimate, Sales $606.030M Beat $591.672M Estimate
- Concentra Group Holdings Raises FY2026 Sales Guidance from $2.275B-$2.375B to $2.325B-$2.375B vs $2.334B Est
- Truist Securities Maintains Buy on Concentra Group Holdings, Raises Price Target to $37
Your note
Sign in to keep a note on CON — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CONSER JONATHAN P. | Officer | Stock Award(Grant) | Nov 3, 2025 | 120,000 |
| DELORIMIER JOHN A. | Officer | Stock Award(Grant) | Nov 3, 2025 | 120,000 |
| DICANIO MATTHEW T. | President | Stock Award(Grant) | Nov 3, 2025 | 360,000 |
| GALLARA GIOVANNI | Officer | Stock Award(Grant) | Nov 3, 2025 | 120,000 |
| GILBERT GREG M. | Officer | Stock Award(Grant) | Nov 3, 2025 | 120,000 |
| KOSUTH MICHAEL A. | Officer | Stock Award(Grant) | Nov 3, 2025 | 120,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 13.92% | 17,753,714 | 717.07M | Jun 29, 2026 |
| Price (T.Rowe) Associates Inc | 13.89% | 17,715,257 | 715.52M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.35% | 6,817,456 | 275.36M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.02% | 5,129,815 | 207.19M | Jun 29, 2026 |
| State Street Corporation | 3.80% | 4,840,099 | 195.49M | Jun 29, 2026 |
| Jennison Associates LLC | 2.55% | 3,256,435 | 131.53M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| T. Rowe Price Mid-Cap Value Fund, Inc. | 5.79% | 7,387,198 | 298.37M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.54% | 7,062,689 | 285.26M | Sep 29, 2026 |
| TR PRICE-Price (T.Rowe) Mid-Cap Value Equity Trust | 3.72% | 4,745,782 | 191.68M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.86% | 3,645,920 | 147.26M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.39% | 3,051,771 | 123.26M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.07% | 2,643,860 | 106.79M | Jun 29, 2026 |